Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

PDSB PDS Biotechnology Corp Forecast, Technical & Fundamental Analysis

a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Industry Biotechnology
PDSB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For PDSB
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PDSB
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For PDSB
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

PDSB is expected to report earnings to rise 12.07% to -32 cents per share on March 27

PDS Biotechnology Corp PDSB Stock Earnings Reports
Q4'24
Est.
$-0.32
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.10
Q1'24
Beat
by $0.07
Q4'23
Beat
by $0.09
The last earnings report on November 14 showed earnings per share of -28 cents, beating the estimate of -30 cents. With 117.37K shares outstanding, the current market capitalization sits at 75.75M.
A.I. Advisor
published General Information

General Information

a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
303A College Road
Phone
+1 800 208-3343
Employees
25
Web
https://www.pdsbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBM214.604.35
+2.07%
International Business Machines Corp
GOTU2.60N/A
N/A
Gaotu Techedu
ALSN115.21-0.77
-0.66%
Allison Transmission Holdings
OUST8.88-0.14
-1.55%
Ouster
VTGN2.61-0.06
-2.25%
VistaGen Therapeutics

PDSB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-3.34%
AXON - PDSB
43%
Loosely correlated
-0.06%
PRME - PDSB
40%
Loosely correlated
-5.68%
VERV - PDSB
40%
Loosely correlated
-5.99%
BPMC - PDSB
40%
Loosely correlated
+0.22%
RXRX - PDSB
39%
Loosely correlated
-3.67%
More